155 related articles for article (PubMed ID: 27529229)
1. 25(OH)D Is Effective to Repress Human Cholangiocarcinoma Cell Growth through the Conversion of 25(OH)D to 1α,25(OH)₂D₃.
Chiang KC; Yeh CN; Huang CC; Yeh TS; S Pang JH; Hsu JT; Chen LW; Kuo SF; Kittaka A; Chen TC; Juang HH
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27529229
[TBL] [Abstract][Full Text] [Related]
2. MART-10 represses cholangiocarcinoma cell growth and high vitamin D receptor expression indicates better prognosis for cholangiocarcinoma.
Chiang KC; Yeh TS; Huang CC; Chang YC; Juang HH; Cheng CT; Pang JS; Hsu JT; Takano M; Chen TC; Kittaka A; Hsiao M; Yeh CN
Sci Rep; 2017 Mar; 7():43773. PubMed ID: 28256614
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma cells express 25(OH)D-1α-hydroxylase and are able to convert 25(OH)D to 1α,25(OH)₂D, leading to the 25(OH)D-induced growth inhibition.
Chiang KC; Yen CL; Yeh CN; Hsu JT; Chen LW; Kuo SF; Wang SY; Sun CC; Kittaka A; Chen TC; Yeh TS; Hsu SY; Juang HH
J Steroid Biochem Mol Biol; 2015 Nov; 154():47-52. PubMed ID: 26170242
[TBL] [Abstract][Full Text] [Related]
4. Molecular Mechanism(s) Involved in 25-Hydroxyvitamin D's Antiproliferative Effects in CYP27B1-transfected LNCaP Cells.
Banks M; Holick MF
Anticancer Res; 2015 Jul; 35(7):3773-9. PubMed ID: 26124321
[TBL] [Abstract][Full Text] [Related]
5. 22-oxa-1,25-dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculture of cholangiocarcinoma.
Seubwai W; Wongkham C; Puapairoj A; Okada S; Wongkham S
Cancer; 2010 Dec; 116(23):5535-43. PubMed ID: 20681031
[TBL] [Abstract][Full Text] [Related]
6. Expression of 25-hydroxyvitamin D-1alpha-hydroxylase (1alphaOHase, CYP27B1) splice variants in HaCaT keratinocytes and other skin cells: modulation by culture conditions and UV-B treatment in vitro.
Seifert M; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3659-67. PubMed ID: 19667162
[TBL] [Abstract][Full Text] [Related]
7. Tumoral Vitamin D Synthesis by CYP27B1 1-α-Hydroxylase Delays Mammary Tumor Progression in the PyMT-MMTV Mouse Model and Its Action Involves NF-κB Modulation.
Li J; Luco AL; Ochietti B; Fadhil I; Camirand A; Reinhardt TA; St-Arnaud R; Muller W; Kremer R
Endocrinology; 2016 Jun; 157(6):2204-16. PubMed ID: 27119753
[TBL] [Abstract][Full Text] [Related]
8. Nongenomic effects of 1α,25-dihydroxyvitamin D
Hirota Y; Nakagawa K; Mimatsu S; Sawada N; Sakaki T; Kubodera N; Kamao M; Tsugawa N; Suhara Y; Okano T
Biochem Biophys Res Commun; 2017 Jan; 483(1):359-365. PubMed ID: 28025137
[TBL] [Abstract][Full Text] [Related]
9. Eldecalcitol is more effective in promoting osteogenesis than alfacalcidol in Cyp27b1-knockout mice.
Hirota Y; Nakagawa K; Isomoto K; Sakaki T; Kubodera N; Kamao M; Osakabe N; Suhara Y; Okano T
PLoS One; 2018; 13(10):e0199856. PubMed ID: 30281599
[TBL] [Abstract][Full Text] [Related]
10. Selective use of multiple vitamin D response elements underlies the 1 alpha,25-dihydroxyvitamin D3-mediated negative regulation of the human CYP27B1 gene.
Turunen MM; Dunlop TW; Carlberg C; Väisänen S
Nucleic Acids Res; 2007; 35(8):2734-47. PubMed ID: 17426122
[TBL] [Abstract][Full Text] [Related]
11. Kinetic studies of 25-hydroxy-19-nor-vitamin D3 and 1 alpha,25-dihydroxy-19-nor-vitamin D3 hydroxylation by CYP27B1 and CYP24A1.
Urushino N; Nakabayashi S; Arai MA; Kittaka A; Chen TC; Yamamoto K; Hayashi K; Kato S; Ohta M; Kamakura M; Ikushiro S; Sakaki T
Drug Metab Dispos; 2007 Sep; 35(9):1482-8. PubMed ID: 17553915
[TBL] [Abstract][Full Text] [Related]
12. 1alpha-Hydroxylase and the action of vitamin D.
Hewison M; Zehnder D; Bland R; Stewart PM
J Mol Endocrinol; 2000 Oct; 25(2):141-8. PubMed ID: 11013342
[TBL] [Abstract][Full Text] [Related]
13. Thyroid hormones decrease plasma 1α,25-dihydroxyvitamin D levels through transcriptional repression of the renal 25-hydroxyvitamin D3 1α-hydroxylase gene (CYP27B1).
Kozai M; Yamamoto H; Ishiguro M; Harada N; Masuda M; Kagawa T; Takei Y; Otani A; Nakahashi O; Ikeda S; Taketani Y; Takeyama K; Kato S; Takeda E
Endocrinology; 2013 Feb; 154(2):609-22. PubMed ID: 23307792
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the biological effects of exogenous and endogenous 1,25-dihydroxyvitamin D
Yang D; Anderson PH; Turner AG; Morris HA; Atkins GJ
J Steroid Biochem Mol Biol; 2016 Nov; 164():374-378. PubMed ID: 26949105
[TBL] [Abstract][Full Text] [Related]
15. Expanding role for vitamin D in chronic kidney disease: importance of blood 25-OH-D levels and extra-renal 1alpha-hydroxylase in the classical and nonclassical actions of 1alpha,25-dihydroxyvitamin D(3).
Jones G
Semin Dial; 2007; 20(4):316-24. PubMed ID: 17635821
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of vitamin D3 synthesis leads to enhanced cholangiocarcinoma growth.
Kennedy L; Baker K; Hodges K; Graf A; Venter J; Hargrove L; Harris R; Harnish E; Meng F; Francis H
Dig Liver Dis; 2013 Apr; 45(4):316-22. PubMed ID: 23375797
[TBL] [Abstract][Full Text] [Related]
17. Constitutive expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in a transformed human proximal tubule cell line: evidence for direct regulation of vitamin D metabolism by calcium.
Bland R; Walker EA; Hughes SV; Stewart PM; Hewison M
Endocrinology; 1999 May; 140(5):2027-34. PubMed ID: 10218951
[TBL] [Abstract][Full Text] [Related]
18. Purified mouse CYP27B1 can hydroxylate 20,23-dihydroxyvitamin D3, producing 1alpha,20,23-trihydroxyvitamin D3, which has altered biological activity.
Tang EK; Li W; Janjetovic Z; Nguyen MN; Wang Z; Slominski A; Tuckey RC
Drug Metab Dispos; 2010 Sep; 38(9):1553-9. PubMed ID: 20554701
[TBL] [Abstract][Full Text] [Related]
19. Equivalent anticancer activities of dietary vitamin D and calcitriol in an animal model of breast cancer: importance of mammary CYP27B1 for treatment and prevention.
Krishnan AV; Swami S; Feldman D
J Steroid Biochem Mol Biol; 2013 Jul; 136():289-95. PubMed ID: 22939886
[TBL] [Abstract][Full Text] [Related]
20. 25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue.
Segersten U; Holm PK; Björklund P; Hessman O; Nordgren H; Binderup L; Akerström G; Hellman P; Westin G
Breast Cancer Res; 2005; 7(6):R980-6. PubMed ID: 16280049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
